Exosomes from PC patients contain >10-kb fragments of double-stranded genomic DNA with detectable mutations in KRAS and p53. In addition, WGS of exosomal DNA can determine genomic DNA mutations for cancer prediction, treatment, and therapy resistance. This evidence concerns the gene TP53 and cancer.